Acute Stroke: Clinical Trials

28 trials for Acute Stroke, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed, 6 unknown, 2 terminated, 1 recruiting. 28 Phase 2, 6 Phase 3, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 228Completed 18, Unknown 6, Terminated 2, Recruiting 1, Withdrawn 1
Phase 36Completed 3, Unknown 2, Recruiting 1
Phase 15Completed 2, Terminated 1, Unknown 1, Withdrawn 1

Follow Acute Stroke: new trials by email Literature Review of Acute Stroke trials Research Report on Acute Stroke

Trials (filtered) newest first · largest first

All 28 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation Study of Early Administration of Evolocumab After Thrombolysis in Patients With Atherosclerotic Acute Ischemic Stroke
Ivolumab 420mg (three vials) - Acute Stroke
Phase 2CompletedThe Affiliated Hospital of Xuzhou Medical University1322025-10-302026-09-10
Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke
Tirofiban Hydrochloride, Standard medical treatment (SMT) - Acute Stroke, Ischemic Stroke, Acute
Phase 2 / Phase 3UnknownCapital Medical University3022024-11-202024-10-29
The Prehospital Administration of Normobaric Oxygen in Suspected Stroke
NBO - Acute Stroke, Ischemic Stroke, Acute
Phase 2UnknownCapital Medical University1002022-01-212022-04-28
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
Recombinant human tissue kallikrein, Placebo for DM199 Solution for Injection - Acute Stroke, Ischemic Stroke
Phase 2 / Phase 3RecruitingDiaMedica Therapeutics Inc7282021-11-072026-09-14
Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease
Clopidogrel, Aspirin, Atorvastatin - Acute Stroke, Dual Antiplatelet Therapy
Phase 2CompletedChang Gung Memorial Hospital3762021-03-232025-03-26
Phase Ib/IIa Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke
ApTOLL, Placebo - Stroke, Acute Stroke
Phase 1 / Phase 2CompletedaptaTargets S.L.1512020-10-282022-10-21
Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke
Tirofiban Hydrochloride, Oral antiplatelet - Acute Stroke
Phase 2 / Phase 3UnknownCapital Medical University4202020-09-122022-07-19
Remote Ischemic Conditioning Paired With Endovascular Treatment for Acute Ischemic Stroke
Remote ischemic conditioning., Endovascular treatment., Sham remote ischemic conditioning - Acute Stroke
Phase 2UnknownCapital Medical University1802020-08-012020-07-27
Blood Pressure After Endovascular Stroke Therapy-II
Nicardipine, Labetalol, Hydralazine - Acute Stroke, Endovascular Thrombectomy
Phase 2CompletedUniversity of Cincinnati1202020-01-172023-10-12
Measuring Ambulation, Motor, and Behavioral Outcomes With Post-Stroke Fluoxetine in Tanzania
Fluoxetine 20 MG Oral Tablet - Acute Stroke, Stroke, Ischemic
Phase 2CompletedMassachusetts General Hospital342019-11-262022-05-25
Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients
human umbilical cord mesenchymal stem cells, Placebo, standardized treatment - Infarction, Middle Cerebral Artery, Infarction, Anterior Cerebral Artery
Phase 1 / Phase 2UnknownShanghai East Hospital1202019-01-132023-04-18
PMZ-1620 (Sovateltide) in Acute Ischemic Stroke Patients
Normal Saline along with standard treatment, PMZ-1620 along with standard treatment - Acute Stroke, Cerebral Ischemia
Phase 2CompletedPharmazz, Inc.402018-01-192025-05-12
Safety and Efficacy of Glibenclamide Combined With Rt-PA in Acute Cerebral Embolism
Glibenclamide, Placebo - Acute Stroke
Phase 2 / Phase 3CompletedNanfang Hospital, Southern Medical University3062018-01-012023-06-12
Fluoxetine for Visual Recovery After Ischemic Stroke
Fluoxetine, Placebo - Acute Stroke, Visual Field Loss
Phase 2TerminatedBogachan Sahin172016-05-012021-10-13
Blood Pressure Control in Acute Ischemic Stroke
Early intensive BP control - Blood Pressure, Acute Stroke
Phase 2 / Phase 3CompletedNational University of Singapore542014-12-012019-04-16
PG2 Injection 500 mg in Acute Stroke Study (Pass)
PG2, placebo - Acute Stroke
Phase 2CompletedChina Medical University Hospital862012-06-012016-11-04
Efficacy of Whole Extract of Licorice in Neurological Improvement of Patients After Acute Ischemic Stroke
Licorice whole extract, Placebo - Acute Stroke
Phase 1 / Phase 2CompletedShiraz University of Medical Sciences752012-06-012015-06-16
Intra-arterial Magnesium Administration for Acute Stroke
Magnesium Sulfate - Acute Stroke
Phase 1 / Phase 2TerminatedUniversity of Southern California42012-03-012017-08-28
Donepezil Trial for Motor Recovery in Acute Stroke
Donepezil, Placebo - Acute Stroke
Phase 1 / Phase 2WithdrawnImperial College London2011-11-012024-04-12
PHANTOM-S: The Pre-Hospital Acute Neurological Therapy and Optimization of Medical Care in Stroke Patients - Study
Stroke Emergency Mobile Unit (STEMO) - Acute Stroke
Phase 2CompletedCharite University, Berlin, Germany6142011-05-012015-09-15

Showing 20 of 28. Sign in to see all of them.

Narrower conditions

Stroke (28)  ·  Ischemic Stroke (15)  ·  Cerebral Infarction (2)  ·  Brain Edema (1)  ·  Brain Infarction (1)  ·  Brain Ischemia (1)  ·  Cerebrovascular Disorders (1)  ·  Hemianopsia (1)  ·  Hemiplegia (1)  ·  Hyperglycemia (1)  ·  Infarction, Anterior Cerebral Artery (1)  ·  Infarction, Middle Cerebral Artery (1)  ·  Infarction, Posterior Cerebral Artery (1)  ·  Insulin Resistance (1)  ·  Ischemia (1)

Broader conditions

Brain Diseases (28)  ·  Cardiovascular Diseases (28)  ·  Central Nervous System Diseases (28)  ·  Nervous System Diseases (28)  ·  Vascular Diseases (28)  ·  Cerebrovascular Disorders (27)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Pathologic Processes (3)  ·  Brain Ischemia (2)  ·  Glucose Metabolism Disorders (2)  ·  Infarction (2)  ·  Ischemia (2)  ·  Metabolic Diseases (2)  ·  Necrosis (2)  ·  Neurologic Manifestations (2)

Interventions

Fluoxetine (2)  ·  Insulin (2)  ·  Tirofiban (2)  ·  Aspirin (1)  ·  Atorvastatin (1)  ·  Clopidogrel (1)  ·  DM199 (1)  ·  Donepezil (1)  ·  Glyburide (1)  ·  Hydralazine (1)  ·  Injections (1)  ·  Labetalol (1)  ·  Magnesium Sulfate (1)  ·  Nicardipine (1)  ·  Rosuvastatin Calcium (1)

Sponsors

Capital Medical University (4)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Bogachan Sahin (1)  ·  Chang Gung Memorial Hospital (1)  ·  Charite University, Berlin, Germany (1)  ·  China Medical University Hospital (1)  ·  DiaMedica Therapeutics Inc (1)  ·  Fudan University (1)  ·  Imperial College London (1)  ·  Lee Schwamm (1)  ·  Manipal Acunova Ltd. (1)  ·  Massachusetts General Hospital (1)  ·  Nanfang Hospital, Southern Medical University (1)  ·  National University of Singapore (1)  ·  Pharmazz, Inc. (1)

Countries

China (7)  ·  United States (7)  ·  France (3)  ·  Germany (3)  ·  United Kingdom (3)  ·  India (2)  ·  Spain (2)  ·  Taiwan (2)  ·  Belgium (1)  ·  Canada (1)  ·  Georgia (1)  ·  Hungary (1)  ·  Iran (1)  ·  Poland (1)  ·  Romania (1)

Top investigators

Anil Gulati (1)  ·  Charles Burgar, MD (1)  ·  Chung Y. Hsu, PhD (1)  ·  Dr. Kameshwar Prasad, MBBS, MD (1)  ·  Dr. R.S Sarkar (1)  ·  Dr. Sharat Joshi, MBBS,MD, DM (1)  ·  Dr. Sudesh Kumar Prabhakar, MBBS, MD, DM (1)  ·  Dr. Usha Kant Misra, MBBS, MD, DM (1)  ·  Eva Mistry, MBBS (1)  ·  Farrah J Mateen, MD, PhD (1)  ·  Gang Li, Doctor (1)  ·  Heinrich Audebert, Prof (1)  ·  Jay Volpi, M.D. (1)  ·  Jeffrey Saver, MD (1)  ·  Keith Muir, MD (1)

Results publications

PMID 38648030, PMID 16282547, PMID 16336965, PMID 16614616, PMID 18468545, PMID 19570514, PMID 20966420, PMID 22700528, PMID 22960888, PMID 23197640, PMID 23370205, PMID 23523460, PMID 24610327, PMID 24756512, PMID 25378424, PMID 25402214, PMID 25530442, PMID 25634000, PMID 25671797, PMID 25793765, PMID 26251255, PMID 27328702, PMID 27834750, PMID 29127270, PMID 29689135, PMID 30290680, PMID 31570084, PMID 32527232, PMID 33230035, PMID 33428177, PMID 34174279, PMID 34836908, PMID 36166771, PMID 36908619, PMID 37256974, PMID 37338893, PMID 37668620, PMID 37965431, PMID 39036300, PMID 39314261, PMID 39950764, PMID 40012523, PMID 40726739, PMID 41583626

NIH funding

K23NS113858 (1)